Al Jazeera Examines Nigeria’s Drive To Increase Access To Injectable Anti-Malarial Drug

Al Jazeera: The Cure: Mission Malaria
“…Injectable artesunate is a rapidly acting drug that kills the parasites that cause malaria. In 2010, the World Health Organization authorized aid agencies to supply the drug as the preferred first line treatment for severe malaria. … But despite its effectiveness, injectable artesunate is still out of reach for millions of people who need it. … Join Dr. Javid Abdelmoneim in Nigeria for this special episode of The Cure, to see how the international drive to increase access to injectable artesunate is saving young children’s lives” (6/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.